218 related articles for article (PubMed ID: 22559715)
1. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
[TBL] [Abstract][Full Text] [Related]
2. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
[TBL] [Abstract][Full Text] [Related]
3. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
[TBL] [Abstract][Full Text] [Related]
4. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
[TBL] [Abstract][Full Text] [Related]
5. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
Rayan GM; Tomasek JJ
Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
[TBL] [Abstract][Full Text] [Related]
6. The collagen changes of Dupuytren's contracture.
Murrell GA; Francis MJ; Bromley L
J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture.
Satish L; LaFramboise WA; O'Gorman DB; Johnson S; Janto B; Gan BS; Baratz ME; Hu FZ; Post JC; Ehrlich GD; Kathju S
BMC Med Genomics; 2008 Apr; 1():10. PubMed ID: 18433489
[TBL] [Abstract][Full Text] [Related]
10. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
11. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.
Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S
BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724
[TBL] [Abstract][Full Text] [Related]
12. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
15. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
16. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
17. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
[TBL] [Abstract][Full Text] [Related]
18. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
19. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S
BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]